China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Perioperative Trastuzumab Rezetecan and Trastuzumab plus Sintilimab in the LocallyAdvanced HER2 positive Gastric Cancer (Periscope-06): a Phase 2 Trial'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600135376
Registration Time: 2026/10/29
Type: Interventional study
Primary Sponsor: Sun Yat-Sen University Cancer Center
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=347130
Published by HT Digital Content Services with permission from Health Daily Digest....